BWAM
REGN icon

Boyd Watterson Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Boyd Watterson Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$840K Buy
1,087
+15
+1% +$11.5K 0.26% 72
2025
Q4 		$827K Buy
1,072
+20
+2% +$13.6K 0.24% 72
2025
Q3 		$592K Buy
1,052
+85
+9% +$48.1K 0.18% 91
2025
Q2 		$508K Buy
967
+77
+9% +$43K 0.16% 93
2025
Q1 		$564K Sell
890
-15
-2% -$10.3K 0.18% 91
2024
Q4 		$645K Sell
905
-286
-24% -$240K 0.18% 81
2024
Q3 		$1.25M Sell
1,191
-4
-0.3% -$4.45K 0.34% 62
2024
Q2 		$1.26M Hold
1,195
– – 0.36% 57
2024
Q1 		$1.15M Buy
1,195
+276
+30% +$262K 0.41% 54
2023
Q4 		$807K Sell
919
-17
-2% -$14K 0.32% 63
2023
Q3 		$770K Sell
936
-11
-1% -$8.64K 0.34% 62
2023
Q2 		$680K Hold
947
– – 0.27% 75
2023
Q1 		$778K Sell
947
-13
-1% -$9.8K 0.32% 73
2022
Q4 		$693K Buy
960
+9
+0.9% +$6.64K 0.29% 81
2022
Q3 		$655K Sell
951
-15
-2% -$9.44K 0.3% 79
2022
Q2 		$571K Sell
966
-6
-0.6% -$3.9K 0.24% 87
2022
Q1 		$679K Buy
972
+20
+2% +$12.7K 0.25% 93
2021
Q4 		$601K Hold
952
– – 0.2% 98
2021
Q3 		$576K Buy
952
+143
+18% +$88.8K 0.21% 100
2021
Q2 		$452K Sell
809
-1,443
-64% -$731K 0.18% 111
2021
Q1 		$1.07M Buy
2,252
+488
+28% +$238K 0.47% 68
2020
Q4 		$852K Buy
+1,764
New +$952K 0.41% 74

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Boyd Watterson Asset Management's REGN Position: Q1 2026 in Review

Boyd Watterson Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 1.4% in Q1 2026, buying an estimated $11.5K and bringing the position to 1,087 shares worth $840K. The position accounts for 0.26% of the portfolio, ranked #72.

Boyd Watterson Asset Management first reported a position in REGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.26M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Boyd Watterson Asset Management held 1,087 shares of Regeneron Pharmaceuticals worth $840K as of Q1 2026.
  • Boyd Watterson Asset Management bought 15 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $11.5K.
  • Regeneron Pharmaceuticals made up 0.26% of Boyd Watterson Asset Management's portfolio in Q1 2026, its #72 holding.
  • Boyd Watterson Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Boyd Watterson Asset Management's Regeneron Pharmaceuticals position peaked at $1.26M in Q2 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Boyd Watterson Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.